Community/Retail

Canomiks enhances consumer trust in the supplement industry through WhatToTrust, a platform evaluating product safety, efficacy, and scientific validation.

CVS expands its footprint by acquiring 626 Rite Aid and Bartell locations, enhancing pharmacy access amid industry challenges.

Research reveals the impact of SSRIs on pregnancy, highlighting risks and benefits for maternal mental health and fetal development.

In a Swedish cohort, young women with symptomatic long COVID were found to be at higher risk of postural orthostatic tachycardia syndrome (POTS), conferring additional burden.

GLP-1 receptor agonists show potential as innovative treatments for alcohol and substance use disorders, addressing critical public health needs.

Primary care clinics enhance diabetes management by implementing continuous glucose monitors, improving access to essential care for patients nationwide.

Ron Lanton explains that increased pharmaceutical tariffs could drive up costs, reduce margins, and strain pharmacy supply chains, with few mitigation options available.

ACIP updates COVID-19 vaccine guidance, emphasizing shared decision-making, while addressing safety concerns and access issues for patients and pharmacists.

The approved indication now includes adults with moderately to severely active ulcerative colitis and Crohn disease who have not been treated with tumor necrosis factor blocking agents.

Higher levels of cyclic adenosine monophosphate (cAMP) may be key to diagnosing asthma and its severity as well as monitoring patients.

The ratio of high-density lipoprotein cholesterol (HDL-C) to low-density lipoprotein cholesterol (LDL-C) can predict cardiovascular disease (CVD) risk in patients with and without diabetes.

CDC layoffs threaten public health surveillance, prompting urgent reinstatement of staff as pharmacists face challenges in community health response.

Each month, Timothy Ulbrich will share lessons on mindset, strategy, and habits to help pharmacists achieve lasting security and financial freedom.

Compared with lower-valent vaccines and PPSV23, higher-valent pneumococcal conjugate vaccines were more cost-effective, especially in high-income countries.

Inhaled insulin Afrezza offers a rapid-acting alternative for children with type 1 diabetes, enhancing blood glucose control and patient satisfaction.

FDA approves Uzedy, an extended-release injectable formulation of risperidone, enhancing treatment options for adults with bipolar I disorder.

The pharmaceutical giant will reportedly lower its drug prices to align with most-favored-nation status.

Public debate intensifies as Robert F. Kennedy Jr compares selective serotonin reuptake inhibitors (SSRIs) to heroin, prompting mental health experts to clarify antidepressant use and withdrawal misconceptions.

A hybrid chatbot that evaluates stages of change in pneumococcal vaccination desires while providing artificial intelligence (AI)-based Q&A opportunities improved uptake in older adults.

The FDA approves Eydenzelt, a biosimilar for retinal diseases, enhancing treatment options for diabetic macular edema and age-related macular degeneration.

Researchers highlight the critical link between school vaccination rates and measles outbreaks, urging targeted public health strategies to combat misinformation and improve MMR coverage.

Discover groundbreaking FDA approvals for innovative treatments, including semaglutide for liver health and bumetanide nasal spray for heart failure.

Explore recent FDA-approved drugs from September 2025.

Ron Lanton advises pharmacies to maintain compliance, explore contingency options, and stay engaged with policymakers during the government shutdown.

Research reveals that poor glycemic control in adolescents with type 1 diabetes significantly increases the risk of developing neuropathy in adulthood.

Tramadol provides only limited pain relief while carrying a significant risk of serious adverse effects.

Discover how supplements support women's health during menopause, enhancing well-being and easing symptoms effectively.

GLP-1 receptor agonists significantly influence FDG-PET-CT scan interpretations, potentially leading to misdiagnosis in cancer detection.